Dn B Asset Management As Abbott Laboratories Transaction History

Dn B Asset Management As

$19.9 Billion
Q2 2024

A detailed history of Dn B Asset Management As transactions in Abbott Laboratories stock. As of the latest transaction made, Dn B Asset Management As holds 526,909 shares of ABT stock, worth $60 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

526,909

Previous 450,489 16.96%

Holding current value

$60 Million

Previous $51.2 Million 6.93%

% of portfolio

0.28%

Previous 0.28%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 05, 2024	BUY	$100.73 - $112.44 $7.7 Million - $8.59 Million	76,420 Added 16.96%	526,909 $54.8 Million
Q1 2024 Apr 12, 2024	SELL	$109.52 - $120.96 $577,718 - $638,064	-5,275 Reduced 1.16%	450,489 $51.2 Million
Q4 2023 Jan 04, 2024	SELL	$90.19 - $110.4 $1.32 Million - $1.62 Million	-14,678 Reduced 3.12%	455,764 $50.2 Million
Q3 2023 Oct 13, 2023	BUY	$95.53 - $114.62 $1.55 Million - $1.86 Million	16,188 Added 3.56%	470,442 $45.6 Million
Q2 2023 Jul 06, 2023	BUY	$100.78 - $112.29 $981,496 - $1.09 Million	9,739 Added 2.19%	454,254 $49.5 Million
Q1 2023 Apr 20, 2023	BUY	$96.86 - $114.01 $495,535 - $583,275	5,116 Added 1.16%	444,515 $45 Million
Q4 2022 Jan 12, 2023	BUY	$95.06 - $111.52 $1.44 Million - $1.69 Million	15,113 Added 3.56%	439,399 $48.2 Billion
Q3 2022 Oct 11, 2022	SELL	$96.76 - $112.03 $437,548 - $506,599	-4,522 Reduced 1.05%	424,286 $41.1 Million
Q2 2022 Jul 08, 2022	SELL	$102.07 - $123.37 $168,007 - $203,067	-1,646 Reduced 0.38%	428,808 $46.6 Billion
Q1 2022 Apr 08, 2022	BUY	$114.02 - $139.04 $2.25 Million - $2.75 Million	19,755 Added 4.81%	430,454 $50.9 Million
Q4 2021 Jan 12, 2022	BUY	$115.53 - $141.46 $89,420 - $109,490	774 Added 0.19%	410,699 $57.8 Million
Q3 2021 Oct 15, 2021	BUY	$116.66 - $129.06 $4.69 Million - $5.19 Million	40,189 Added 10.87%	409,925 $48.4 Million
Q2 2021 Jul 06, 2021	BUY	$105.79 - $124.53 $3.9 Million - $4.59 Million	36,824 Added 11.06%	369,736 $42.9 Billion
Q1 2021 Apr 15, 2021	BUY	$108.84 - $128.23 $1.31 Million - $1.54 Million	12,023 Added 3.75%	332,912 $39.9 Million
Q4 2020 Jan 19, 2021	BUY	$105.0 - $114.42 $10.5 Million - $11.4 Million	99,964 Added 45.25%	320,889 $35.1 Million
Q3 2020 Oct 14, 2020	BUY	$91.64 - $111.29 $795,526 - $966,108	8,681 Added 4.09%	220,925 $24 Million
Q2 2020 Jul 08, 2020	BUY	$76.57 - $98.0 $925,654 - $1.18 Million	12,089 Added 6.04%	212,244 $19.4 Billion
Q1 2020 Apr 17, 2020	SELL	$62.82 - $91.86 $2.28 Million - $3.33 Million	-36,286 Reduced 15.35%	200,155 $15.8 Million
Q4 2019 Jan 13, 2020	BUY	$78.51 - $87.4 $149,483 - $166,409	1,904 Added 0.81%	236,441 $20.5 Million
Q3 2019 Oct 16, 2019	SELL	$81.84 - $88.74 $4.16 Million - $4.51 Million	-50,824 Reduced 17.81%	234,537 $19.6 Million
Q2 2019 Jul 08, 2019	SELL	$72.88 - $85.0 $3.56 Million - $4.16 Million	-48,915 Reduced 14.63%	285,361 $0
Q1 2019 Apr 11, 2019	SELL	$66.22 - $80.06 $4.09 Million - $4.94 Million	-61,760 Reduced 15.59%	334,276 $0
Q4 2018 Jan 15, 2019	BUY	$65.56 - $74.27 $11.7 Million - $13.3 Million	178,866 Added 82.36%	396,036 $28.6 Million
Q3 2018 Oct 10, 2018	BUY	$60.81 - $73.36 $400,981 - $483,735	6,594 Added 3.13%	217,170 $0
Q2 2018 Jul 06, 2018	BUY	$57.57 - $63.54 $598,728 - $660,816	10,400 Added 5.2%	210,576 $0
Q1 2018 Apr 11, 2018	BUY	$56.27 - $63.62 $967,844 - $1.09 Million	17,200 Added 9.4%	200,176 $0
Q4 2017 Jan 10, 2018	BUY	$53.68 - $57.47 $187,880 - $201,145	3,500 Added 1.95%	182,976 $0
Q3 2017 Oct 11, 2017	BUY	$48.06 - $53.64 $8.63 Million - $9.63 Million	179,476	179,476 $0

Others Institutions Holding ABT

# of Institutions

3,131

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.

Account

Dn B Asset Management As Abbott Laboratories Transaction History